These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 18831725)

  • 21. [Incidence of amplification of the C-erb B2/Her-2/neu gene in human breast cancer].
    Sellami M; Gamoudi M; Krichen K; Kharrat A; Ben Romdhane K; Maalej M
    Arch Inst Pasteur Tunis; 1991; 68(1-2):33-41. PubMed ID: 1687309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Biological features of breast cancer in patients under 35].
    Damenia AO; Turkevich EA; Semiglazov VF; Kochetova IA; Gurbanov SS; Bit-Sava EM; Efimenko AV
    Vopr Onkol; 2007; 53(6):674-6. PubMed ID: 18416136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer single-nucleotide polymorphisms: statistical significance and clinical utility.
    Offit K
    J Natl Cancer Inst; 2009 Jul; 101(14):973-5. PubMed ID: 19567420
    [No Abstract]   [Full Text] [Related]  

  • 24. DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status.
    Conde I; Alfaro JM; Fraile B; Ruíz A; Paniagua R; Arenas MI
    Breast Cancer Res; 2004; 6(3):R140-8. PubMed ID: 15084237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature.
    Brunelli M; Manfrin E; Miller K; Eccher A; Gobbo S; Reghellin D; Chilosi M; Remo A; Martignoni G; Menestrina F; Bonetti F
    J Cutan Pathol; 2009 Jun; 36(6):702-5. PubMed ID: 19515052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Justification of the change from 10% to 30% for the immunohistochemical HER2 Scoring criterion in breast cancer.
    Liu YH; Xu FP; Rao JY; Zhuang HG; Luo XL; Li L; Luo DL; Zhang F; Xu J
    Am J Clin Pathol; 2009 Jul; 132(1):74-9. PubMed ID: 19864236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lineage infidelity and expression of melanocytic markers in human breast cancer.
    Bachmeier BE; Nerlich AG; Mirisola V; Jochum M; Pfeffer U
    Int J Oncol; 2008 Nov; 33(5):1011-5. PubMed ID: 18949364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
    Webster LR; Lee SF; Ringland C; Morey AL; Hanby AM; Morgan G; Byth K; Mote PA; Provan PJ; Ellis IO; Green AR; Lamoury G; Ravdin P; Clarke CL; Ward RL; Balleine RL; Hawkins NJ
    Clin Cancer Res; 2008 Oct; 14(20):6625-33. PubMed ID: 18927304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
    Heintz NH; Leslie KO; Rogers LA; Howard PL
    Arch Pathol Lab Med; 1990 Feb; 114(2):160-3. PubMed ID: 1967929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
    Faratian D; Munro A; Twelves C; Bartlett JM
    Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer.
    Karn T; Metzler D; Ruckhäberle E; Hanker L; Gätje R; Solbach C; Ahr A; Schmidt M; Holtrich U; Kaufmann M; Rody A
    Breast Cancer Res Treat; 2010 Apr; 120(3):567-79. PubMed ID: 19455418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triple-negative breast cancer: disease entity or title of convenience?
    Carey L; Winer E; Viale G; Cameron D; Gianni L
    Nat Rev Clin Oncol; 2010 Dec; 7(12):683-92. PubMed ID: 20877296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tyrosine1248-phosphorylated HER2 expression and HER2 gene amplification in female invasive ductal carcinomas.
    Taniyama K; Ishida K; Toda T; Motoshita J; Kuraoka K; Saito A; Tani Y; Uike T; Teramoto S; Koseki M
    Breast Cancer; 2008; 15(3):231-40. PubMed ID: 18264744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice.
    Dolan M; Snover D
    Am J Clin Pathol; 2005 May; 123(5):766-70. PubMed ID: 15981817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reply to "IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma".
    Egervari K; Szollosi Z; Nemes Z
    J Clin Pathol; 2006 Jun; 59(6):665; author reply 665-6. PubMed ID: 16731611
    [No Abstract]   [Full Text] [Related]  

  • 39. The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas.
    Rhodes A; Sarson J; Assam EE; Dean SJ; Cribb EC; Parker A
    Am J Clin Pathol; 2010 Oct; 134(4):621-32. PubMed ID: 20855644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.
    Vincent-Salomon A; Lucchesi C; Gruel N; Raynal V; Pierron G; Goudefroye R; Reyal F; Radvanyi F; Salmon R; Thiery JP; Sastre-Garau X; Sigal-Zafrani B; Fourquet A; Delattre O;
    Clin Cancer Res; 2008 Apr; 14(7):1956-65. PubMed ID: 18381933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.